Search hospitals > California > Santa Monica
UCLA Hematology Oncology - Santa Monica
Claim this profileSanta Monica, California 90404
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Breast Cancer
Conducts research for Solid Tumors
Conducts research for Skin Cancer
Conducts research for Lung Cancer
91 reported clinical trials
8 medical researchers
Summary
UCLA Hematology Oncology - Santa Monica is a medical facility located in Santa Monica, California. This center is recognized for care of Non-Small Cell Lung Cancer, Breast Cancer, Solid Tumors, Skin Cancer, Lung Cancer and other specialties. UCLA Hematology Oncology - Santa Monica is involved with conducting 91 clinical trials across 94 conditions. There are 8 research doctors associated with this hospital, such as Zev A. Wainberg, Sara Hurvitz, MD, Jonathan W. Goldman, and Saeed Sadeghi.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Zev A. WainbergUCLA3 years of reported clinical research
Expert in Stomach Cancer
Expert in Pancreatic Cancer
33 reported clinical trials
65 drugs studied
Sara Hurvitz, MDUCLA Medical Center / David Geffen School of Medicine3 years of reported clinical research
Expert in Breast Cancer
Studies Uterine Tumors
17 reported clinical trials
24 drugs studied
Jonathan W. GoldmanUCLA / Jonsson Comprehensive Cancer Center6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
14 reported clinical trials
20 drugs studied
Saeed SadeghiUCLA Medical Center10 years of reported clinical research
Studies Cholangiocarcinoma
Studies FGFR2 Mutation
6 reported clinical trials
8 drugs studied
Clinical Trials running at UCLA Hematology Oncology - Santa Monica
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Skin Cancer
Solid Tumors
Pancreatic Cancer
Uterine Tumors
Prostate Cancer
Multiple Myeloma
Colorectal Cancer
MK-2870
for Non-Small Cell Lung Cancer
The purpose of this study is to evaluate sacituzumab tirumotecan versus chemotherapy (docetaxel or pemetrexed) for the treatment of previously-treated non-small cell lung cancer (NSCLC) with exon 19del or exon 21 L858R EGFR mutations (hereafter referred to as EGFR mutations or EGFR-mutated) or any of the follow genomic alterations: ALK gene rearrangements, ROS1 rearrangements, BRAF V600E mutations, NTRK gene fusions, MET exon 14 skipping mutations, RET rearrangements, or less common EGFR point mutations of exon 20 S768I, exon 21 L861Q, or exon 18 G719X mutations. The primary hypotheses are that sacituzumab tirumotecan is: (1) superior to chemotherapy with respect to progression-free survival (PFS) per RECIST 1.1 as assessed by BICR in NSCLC with EGFR mutations; and (2) superior to chemotherapy with respect to overall survival (OS) in NSCLC with EGFR mutations.
Recruiting2 awards Phase 39 criteria
Nivolumab + Relatlimab vs Pembrolizumab with Chemotherapy
for Lung Cancer
The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%
Recruiting2 awards Phase 33 criteria
CoREST Inhibitor + Anti-PD-1 Therapy
for Solid Cancers
This trial is testing a new drug, TNG260, combined with an existing cancer treatment, pembrolizumab, in patients with advanced solid tumors that have an STK11 mutation. TNG260 aims to block proteins that help cancer grow, while pembrolizumab boosts the immune system to fight the cancer. Pembrolizumab has been shown to be an effective and safe therapeutic option for various advanced cancers, including endometrial cancer and melanoma. The study will determine the best dose, safety, and effectiveness of this combination.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UCLA Hematology Oncology - Santa Monica?
UCLA Hematology Oncology - Santa Monica is a medical facility located in Santa Monica, California. This center is recognized for care of Non-Small Cell Lung Cancer, Breast Cancer, Solid Tumors, Skin Cancer, Lung Cancer and other specialties. UCLA Hematology Oncology - Santa Monica is involved with conducting 91 clinical trials across 94 conditions. There are 8 research doctors associated with this hospital, such as Zev A. Wainberg, Sara Hurvitz, MD, Jonathan W. Goldman, and Saeed Sadeghi.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.